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Basic Investigations
Study on the Mechanism of Compound Mistletoe Fluidextract in 
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Qilu Hospital of Shandong University, Jinan 250012, China 
Objective: To observe the effect of Fufang Jisheng Liujin Gao (໡ᮍᆘ⫳⌕⍌㝣 Compound Mistletoe 
Fluidextract) on blood pressure in the spontaneous hypertensive rats (SHR) and the renal hypertensive dogs 
(RHD). Methods: The blood pressure-decreasing effects of single administration and 14-day consecutive 
administration of Compound Mistletoe Fluidextract (CMF) in SHR and RHD were investigated and 
compared with that of Niuhuang Jiangya Wan (⠯咘䰡य़Ќ Bezoar Hypertension-relieving Pills). Results:
Both single administration and 14-day consecutive administration of CMF had significant hypotensive 
effects in SHR and RHD. Conclusion: The hypotensive action of CMF is gradual, but lasts for a longer 
period, with a dose-effect relationship in a range of doses. 
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There are different pathological characteristics 
between hypertension of age and hypertension of the 
middle-age and young people. Hypertension is an 
important factor of death and complicated cardio- 
cerebrovascular diseases for the elderly. With the 
advent of an aging society, it is of very important 
significance to actively and effectively prevent and 
treat senile hypertension. About treatment of 
hypertension with TCM, in the past most doctors 
treated it by clearing away the liver-fire, nourishing 
yin and suppressing hyperactive yang. But such 
practice has indicated that the therapeutic principle 
doesn’t suit the pathological characteristics of senile 
hypertension. However, conventional western 
hypotensors have adverse effects and are not 
appropriate for long-term administration for the 
elderly. While CMF is a new drug of class III of 
Chinese medicine made by the Affiliated Hospital of 
Shandong University of TCM according to the basic 
pathogenic characteristics of kidney qi-deficiency 
which senile hypertension often has, and it functions 
tonifying the kidney and supplementing qi, with 
indications of syndromes with kidney qi-deficiency, 
such as dizziness, headache, tinnitus or deafness, 
soreness and weakness in the loin and knee, 
un-tolerable to cold and hot, fatigue and weakness, 
dribbling urination etc., so it is applicable for the 
senile hypertension patient with the above mentioned 
symptoms. In order to further probe the mechanism 
of CMF in relieving hypertension, the following 
experimental study was carried out. 
EXPERIMENTAL MATERIALS 
Drugs 
VMF was supplied by the Affiliated Hospital of 
Shangdong University of TCM, batch number 
921025, which was mainly composed of Sang Ji 
Sheng (ḥᆘ⫳Ramulus Loranthi), Yin Yang Huo (⎿
㕞㯓 Herba Epimedii), NĦ Zheng Zi (ཇ䋲ᄤ Fructus 
Ligustri Lucidi), Sheng Huang Qi (⫳咘㡾 Radix 
Astragali), Ze Xie (⋑⋏ Rhizoma Alismatis), etc., 
each 0.5 ml containing 1 g of crude drugs. 
Bezoar Hypertension-relieving Pills (BHRP) was 
produced by Tianjin Darentang Pharmaceutical 
Factory, batch number 920913 1.6 g/pill, which was 
ground and made as solutions of 0.04 g/ml and 
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0.1g/ml just before it was used. 
Laboratory Animals 
Spontaneous hypertensive rats (SHR) were purchased 
from the Center of Laboratory Animals, Shanghai 
Institute of Hypertension, and housed in an 
observation room under control of a central air 
conditioning system, at room temperature 25±2ć, 
artificial illuminating 12 h/d, and according to the sex, 
they were fed in separated cages with 43 cm × 27 cm 
× 18 cm, 5 rats in each cage. They were free access to 
water and fed with the cake forage of 21% protein, 
and the forage was added once daily and the fresh tap 
water were replaced twice daily. The room 
temperature was 24±2ć for determination of blood 
pressure. 
The renal hypertensive dogs (RHD) developed by 
cramping left renal artery were housed in 1.5×2.5 m
separated feeding rooms under control of a central air 
conditioning system, at 24±2ć and was free access 
to water, and fed once with routine forage at 7 
o’clock Am and 4o’clock PM every day, respectively.  
Experimental Instruments
CRB-III computerized rat blood pressure and heart 
rate instrument was developed by Shanghai Institute 
of Hypertension. 
EXPERIMENTAL METHODS 
Observation on SHR: 
Single administration: Female and male SHDs, 
weighing 220±20g, were warmed in electro- 
thermostat at 37±1ć for 10 minutes before 
determination of blood pressure and then the systolic 
blood pressure (SBP) of the tail artery and heart rate 
(HR) were indirectly measured by the CRB-III 
computerized rat blood pressure and heart rate 
instrument. Before formal experiment, blood pressure 
measure training was carried out once daily for about 
2 weeks and after the rat adapted to the environment 
and the blood pressure was stable, they were 
randomly divided into 5 groups according to the body 
weight and blood pressure, 12 rats in each group. 
Distilled water was orally administrated into the rats 
of the control group, CMF was orally administered 
into the rats of the medication groups respectively at 
a dose of 0.5 ml/kg, 1ml/kg, and 2 ml/kg 
(corresponding to 4, 8 and 16 folds of clinically 
predicted dosage, respectively), and solution of 
BHRP was administered into the rats of the positive 
control group at a dose of 0.4 g/kg (corresponding to 
8 folds of clinical dosage). The volume of 
administration was 1 ml / 100 g in all the groups. 
SBP and HR were measured before administration 
and 2, 4, 6 and 24 h after admin- istration. The 
differences of mean SBP and HR before and after 
administration were compared with t-test. 
Consecutive administration: The above-mentioned 
blood pressure measurement method was used and 
the SHRs were randomly divided into 5 groups 
according to the blood pressure, 12 rats in each group. 
Distilled water was orally administrated into the rats 
of the control group for 14 consecutive days, CMF 
was orally administered into the rats of the 
medication groups respectively at a dose of 0.5 ml/kg, 
1 ml/kg, and 2 ml/kg (corresponding to 4, 8 and 16 
folds of clinically predicted dosage, respectively) for 
14 consecutive days, and solution of BHRP was 
administered into the rats of the positive control 
group at a dose of 0.4 g/kg (corresponding to 8 folds 
of clinical dosage) for 14 consecutive days. The 
volume of administration was 1 ml / 100 g in all the 
groups. SBP and HR were measured before 
administration every day. SBP and HR of the 
medication groups were compared with those of the 
control group by t-test. 
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Observation on RHD 
Single administration: In the 6 dogs of renal 
hypertension developed by clamping left renal artery, 
the blood pressure of the common carotid artery was 
measured with auscultation, and the heart rate with 
palpation, and at the same time, electrocardiogram 
lead II was recorded. When the blood pressure 
stabilized for 5 days, the stomach catheter was 
inserted for administration. For the control group, 
distilled water was administrated and for the 
medication groups, CMF respectively at a dose of 0.5 
ml/kg, 1 ml/kg (4 and 8 fold of clinical predicted 
dosage), and for the positive control group, BHRP at 
a dose of 0.2 g/kg (about 4 folds of clinical dosage). 
SBP, diastolic blood pressure (DBP) and heart rate 
were measured before administration, 1, 2, 4, 8, 24 h 
after administration. The 6 dogs were alternately 
given once with distilled water, CMF respectively at 
a dose of 0.5 ml/kg, 1 ml/kg, and BHRP at a dose of 
0.2 g/kg, with an interval of 7 days. Paired t-test was 
used for statistical process of the data. 
Consecutive administration: CMF was given to RHD 
with gastric perfusion at a dose of 0.5 ml/kg (4 fold 
of clinical predicted dosage), once every day, for 14 
consecutive days. The blood pressure and heart rate
were measured before administration and 4–6 h after 
administration every day. 
RESULTS
The Hypotensive Effect in SHR
The effect of single administration on the acute high 
blood pressure: Two hours after administration of 
CMF at a dose of 1 ml/kg and 2 ml/kg, hypotensive 
effect appeared and reached the peak 6h after that, 
reducing by 2.39±1.4 and 3.68±2.59 kPa, respectively, 
and 24h after that it did not turn back to the level 
before administration. HR had a slowing tendency 
after administration with no significant difference as 
compared with that before administration (P>0.05). 
Two hours after administration of BHRP at a dose of 
0.4 g/kg, hypotensive effect reached the peak, 
reducing by 5.07±4.53 kPa, and 24h after admin- 
istration, it did not turn back to that before admin- 
istration (P>0.05). Four hours after administration, 
HR slowed significantly down as compared with that 
before administration (P<0.05).  
The effect of consecutive administration on high 
blood pressure: In the control group, the blood 
pressure gradually raised during the experiment. 
After consecutive administration of CMF res- 
pectively at a dose of 0.5 ml/kg, 1 ml/kg, 2 ml/kg, the 
blood pressure slowly reduced, the mean SBP in the 
14 days was reduced by 0.668±0.410, 2.680±0.410 
and 2.390±0.410 kPa, respectively, with  significant 
differences as compared with those of the control 
group (P<0.05 or P<0.01). After administration of 
BHRP at a dose of 0.4 g/kg, the blood pressure 
significantly reduced, the mean blood pressure in the 
14 days was reduced by 1.33–0.400 kPa with a 
significant difference compared with that of the 
control group (P<0.01). Supposing the reduction of 
1.33 kPa in the mean SBP in the 14 days was 
regarded as effective reducing index of blood 
pressure, after consecutive administration of CMF 
respectively at a dose of 0.5 ml/kg, 1 ml/kg, 2 ml/kg 
in SHR, the effective rate for reducing the blood 
pressure would show significant dose-effect relation, 
being 60.0%, 80.0% and 100.0%, respectively. The 
effective rate of BHRP at a dose of 0.4 g/kg was 70% 
(Table 1). CMF did not have significant effects on 
HR in SHR. The above results indicate that after 
consecutive administration of CMF at 0.5 ml/kg – 2 
ml/kg every day in SHR for 14 days, the blood 
pressure slowly reduced, lasting a long period and 
with a significant dose-effect relation. 
Journal of Traditional Chinese Medicine, December 2009, Vol. 29, No. 4 294
Table 1. The effective rate of 14-days consecutive administration of CMF 
for reducing blood pressure in SHR( x fs, n=12)
 Dose (ml/kg) Effective cases Effective rate (%) Reduced value and range of SBP(kPa)
Control  0 0 0±0.800–2.93±0.667 
CMF 0.5 7 60*  -1.598±0.800– -2.94±0.800 
CMF 1.0 9   80.2** -0.671±0.899– -2.78±1.39 
CMF 2.0 12  100.0** 1.330±1.330– -3.33±1.07 
BHRP 0.4 g/kg 7  70.0** 0.133±0.800– -3.60±1.60 
Notes: Reduction of 1.33 kPa in SBP was regarded as effective; Compared with the control group,  
*P<0.05; **P<0.01.
The Hypotensive Effect in RHD 
The acute blood pressure-reducing effect of single 
session of administration: After single administration 
of distilled water, the blood pressure and HR didn’t 
change significantly. 
The blood pressure was reduced by administration of 
CMF at a dose of 0.5 ml/kg and 1ml/kg to a certain 
degree, and reduced to the lowest level about 4 hours 
later, with the greatest reduction of 0.942±0.400 /
0.610±0.498, and 1.33±0.259 / 1.19±0.271 kPa, res- 
pectively, which lasted for a longer period, and 24 h 
later it did not return completely to that before 
administration, with no effect on HR. About 2 h after 
administration of BHRP, the blood pressure-reducing 
effect reached the peak, with the greatest reduction of 
3.6±0.667 / 3.33±0.667 kPa and it lasted for over 24 
h, with no effect on HR. 
The effect of consecutive 14-days administration: In 
the control group, the mean blood pressure in the 14 
days was 23.98±2.77 / 16.29±2.19 kPa, and mean HR 
was 106±12 bpm. 4–6 h after the administration of 
CMF, the high blood pressure was reduced, in the 14 
days it was reduced meanly by 1.33±0.498/ 
1.19±0.659 kPa, and with no effect on HR. After the 
drug was withdrawn, at the fifth day the blood 
pressure was restored to the control level. During the 
treatment period, abnormal behavior was not found in 
the animals and the body weight and ingestive 
amount had no changes.    
DISCUSSION 
Senile hypertension is a special type of hypertension, 
and it is an important background basis and a risk 
factor for senile cardio-cerebrovascular complicated 
diseases, so, active and effective prevention and 
treatment of senile hypertension are of a very 
important significance. CMF is mainly composed of 
Sang Ji Sheng (ḥᆘ⫳ Ramulus Loranthi), Yin Yang 
Huo (⎿㕞㯓 Herba Epimedii), NĦ Zheng Zi (ཇ䋲ᄤ
Fructus Ligustri Lucidi), etc, which have been proved 
by pharmacological researches to have the function 
of relieving hypertension to a certain degree. 1,2 This 
study indicates that administration of different doses 
of CMF in SHR and RHD has a significant anti- 
hypertensive action, 4–6 h after administration 
reaching the peak, and 24 h after of administration of 
the high dose of CMF, the blood pressure does not 
turn back to the level before administration, with no 
significant effect on HR; consecutive administration 
of CMF has significant antihypertensive action with 
no obvious drug-resistant phenomenon in SHR and 
RHD. 
At present, SHR is an animal model of the most 
similar to human primary hypertension acknow- 
ledged internationally, and the pathogenic factors 
include neurogenic and non-neurogenic, but at 
present, more clear and definite factors are increase 
of total peripheral resistance, active participation of 
sympathetic nerve system, reduction of plasma 
prostaglandin (PGI2) synthesis and vascular lesion 
induced by vascular metabolic changes, etc. Renal 
hypertension is caused by increase of plasma renin 
Journal of Traditional Chinese Medicine, December 2009, Vol. 29, No. 4 295
activity.3-6 Therefore, the mechanism of CMF is 
related possibly with changes of the sympathetic 
nerve system function, promotion of synthesis of 
prostaglandin, dilation of peripheral blood vessels, 
reduction of peripheral resistance and inhibition of 
plasma renin activity, etc. In short, CMF slowly 
reduces high blood pressure, lasting a longer period. 
During administration, the body weight, ingestive 
amount and behavior do not have obvious changes 
with no adverse effects on gastrointestinal tract. It is 
an effective medicine for treatment of senile 
hypertension. 
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